Corteva (NYSE:CTVA) Stock Rating Raised to "Overweight" at JPMorgan Chase & Co.

Corteva (NYSE:CTVA - Get Free Report) was upgraded by stock analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has a $19.00 target price on the stock. JPMorgan Chase & Co.'s price target points to a potential upside of 52.82% from the company's previous close.

Several other equities research analysts also recently weighed in on CTVA. Zacks Research downgraded shares of Corteva from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 11th. New Street Research set a $17.00 target price on shares of Corteva in a research note on Monday. Argus reaffirmed a "buy" rating and set a $91.00 target price on shares of Corteva in a research note on Friday, September 18th. Morgan Stanley reaffirmed an "overweight" rating and set a $18.00 target price on shares of Corteva in a research note on Friday. Finally, KeyCorp assumed coverage on shares of Corteva in a research note on Thursday, September 17th. They set a "sector weight" rating on the stock. Fifteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, Corteva has a consensus rating of "Moderate Buy" and an average price target of $73.95.

Corteva Price Performance

Shares of CTVA opened at $12.43 on Tuesday. Corteva has a fifty-two week low of $11.74 and a fifty-two week high of $90.97. The firm's 50 day moving average price is $77.32 and its 200 day moving average price is $80.10. The company has a market cap of $8.30 billion, a P/E ratio of 8.23, a PEG ratio of 0.37 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA - Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the prior year, the firm earned $2.20 EPS. The firm's revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts forecast that Corteva will post 3.72 earnings per share for the current fiscal year.

Institutional Trading of Corteva

A number of large investors have recently bought and sold shares of the business. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Corteva by 200.2% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 5,643 shares of the company's stock worth $438,000 after acquiring an additional 3,763 shares during the period. QRG Capital Management Inc. lifted its stake in shares of Corteva by 5.4% in the 2nd quarter. QRG Capital Management Inc. now owns 76,984 shares of the company's stock worth $6,520,000 after acquiring an additional 3,946 shares during the period. Envestnet Portfolio Solutions Inc. lifted its stake in shares of Corteva by 16.0% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 20,770 shares of the company's stock worth $1,759,000 after acquiring an additional 2,871 shares during the period. Reynders McVeigh Capital Management LLC lifted its stake in shares of Corteva by 26.5% in the 2nd quarter. Reynders McVeigh Capital Management LLC now owns 7,190 shares of the company's stock worth $609,000 after acquiring an additional 1,504 shares during the period. Finally, Sequoia Financial Advisors LLC lifted its stake in shares of Corteva by 18.4% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 41,265 shares of the company's stock worth $3,495,000 after acquiring an additional 6,404 shares during the period. Institutional investors and hedge funds own 81.54% of the company's stock.

Corteva Company Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.